- Home
- DTIL vs BVFL Comparison
DTIL vs BVFL Comparison
Compare DTIL & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DTIL | BVFL |
|---|---|---|
| Founded | 2006 | 1873 |
| Country | United States | United States |
| Employees | N/A | 104 |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.9M | 176.4M |
| IPO Year | 2019 | 2023 |
Fundamental Metrics
Financial Performance| Metric | DTIL | BVFL |
|---|---|---|
| Price | $6.36 | $20.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $45.00 | N/A |
| AVG Volume (30 Days) | ★ 231.4K | 12.5K |
| Earning Date | 05-14-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.19 |
| EPS | N/A | ★ 0.55 |
| Revenue | ★ $1,070,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $38.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.53 | $14.60 |
| 52 Week High | $9.62 | $22.17 |
Technical Indicators
Market Signals| Indicator | DTIL | BVFL |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 51.22 |
| Support Level | N/A | $20.38 |
| Resistance Level | N/A | $21.92 |
| Average True Range (ATR) | 0.00 | 0.72 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 67.76 |
Price Performance
Historical ComparisonAbout DTIL Precision BioSciences Inc.
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
About BVFL BV Financial Inc.
BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. It operates in one segment commercial banking. The company's sources of revenue are derived from interest and dividends earned on loans and investment securities.